ARCHIVES

Marijuana-Derived Drug Less Effective Than Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer PAC Advocated At AACR Meeting

May 23, 1986

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

NCI Sponsors Session At ASCO On Clinical Grant Applications

May 3, 1991